Bharat Serums and Vaccines’ antibody Covid treatment in Phase 2 trials

Bharat Serums and Vaccines’ antibody Covid treatment in Phase 2 trials

Covid-19 cases, especially of the Omicron variant, have been growing in the country and the number of hospitalisations could increase. Biopharmaceutical company Bharat Serums and Vaccines (BSV) has expanded its research and development facilities and capabilities, with its work on Covid-19 antibody development entering Phase 2 trials. Sanjiv Navangul, MD and CEO, BSV, said the … Read more

Covid-19: Prolonged or severe illness leads to higher antibody levels, study finds

Covid-19: Prolonged or severe illness leads to higher antibody levels, study finds

Higher antibody levels over a period of time were also associated with persistent symptoms People with severe or long-lasting Covid-19 symptoms are more likely to develop high antibody levels needed to fight future infections, a new Rutgers University study has found. The paper, published in The Journal of Infectious Diseases, was part of the larger Rutgers … Read more